Skip over generic navigation
Skip over primary navigation
Skip over visual
Skip over functional column
LAFAYETTE, Ind., June 14, 2012
Evonik Degussa Corporation’s Tippecanoe Laboratories will sponsor the VIP Center during the community’s 2012 Taste of Tippecanoe, the major fund raising event for the Tippecanoe Arts Federation scheduled for Saturday, June 16. Evonik will also staff a corporate booth to familiarize residents with the advanced pharmaceutical ingredients Evonik manufactures at its Lilly Road site. “This is the 31st year of the festival and Evonik’s Tippecanoe Laboratories has been a part of Taste of Tippecanoe almost since the start,” said Mindy Stinson, Director of Human Resources at Evonik Degussa Corporation’s Tippecanoe Laboratories. “This is one of the few times of the year the entire community gets together to have fun. Evonik is an integral part of the Lafayette community and we believe it is extremely important to participate in activities such as the Taste of Tippecanoe.” Located in the Big Four Depot overlooking the Wabash River, the VIP Center is where individuals, businesses and organizations that help to support the arts community through the Taste of Tippecanoe are recognized and thanked for their dedication to the community’s development and growth. As part of its Taste of Tippecanoe sponsorship, three TV segments featuring Evonik employees Amanda Cleaveland, Jason Parker and Isaac Rivera will be broadcast on the JumboTron throughout the day. Stinson noted that the Taste of Tippecanoe will have four music stages running continuously with rock, jazz, gospel, world beats, Americana and blues & funk while residents sample food from more than three dozen restaurants. “It’s a culinary and musical celebration for the arts,” she added. “More than 100 regional arts organizations will benefit from the funds raised from the Taste of Tippecanoe event.” The Taste of Tippecanoe starts at 4 p.m. on Saturday, June 16, and usually attracts 30,000-40,000 people. Evonik Degussa Corporation’s Tippecanoe Laboratories manufactures a variety of specialty chemicals for ingredients in pharmaceutical medications that treat cancer, osteoporosis, lymphoma and fibromyalgia. For additional information about Evonik in North America, please visit our website: www.evonik.com/north-america.
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Evonik benefits specifically from its innovative prowess and integrated technology platforms. Evonik is active in over 100 countries around the world. In fiscal 2011 more than 33,000 employees generated sales of around €14.5 billion and an operating profit (adjusted EBITDA) of about €2.8 billion.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.